{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T14:38:24Z","timestamp":1778855904988,"version":"3.51.4"},"reference-count":31,"publisher":"Hindawi Limited","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":928,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neurol Scand"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1111\/ane.12086","type":"journal-article","created":{"date-parts":[[2013,2,15]],"date-time":"2013-02-15T07:24:13Z","timestamp":1360913053000},"page":"91-99","source":"Crossref","is-referenced-by-count":19,"title":["Indirect comparison of clobazam and other therapies for Lennox-Gastaut syndrome"],"prefix":"10.1155","volume":"128","author":[{"given":"J. A.","family":"Cramer","sequence":"first","affiliation":[{"name":"Houston; TX; USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Sapin","sequence":"additional","affiliation":[{"name":"Global Outcomes Research; Lundbeck SAS; Paris; France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Fran\u00e7ois","sequence":"additional","affiliation":[{"name":"Global Outcomes Research; Lundbeck SAS; Paris; France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2013,2,15]]},"reference":[{"key":"10.1111\/ane.12086-BIB0001|ane12086-cit-0001","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S1474-4422(08)70292-8","article-title":"Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology","volume":"8","author":"Arzimanoglou","year":"2009","journal-title":"Lancet Neurol"},{"issue":"Suppl 5","key":"10.1111\/ane.12086-BIB0002|ane12086-cit-0002","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1528-1167.2011.03177.x","article-title":"Definition and natural history of Lennox-Gastaut syndrome","volume":"52","author":"Camfield","year":"2011","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12086-BIB0003|ane12086-cit-0003","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1056\/NEJM200006223422506","article-title":"A comparison of observational studies and randomized, controlled trials","volume":"342","author":"Benson","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/ane.12086-BIB0004|ane12086-cit-0004","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jama.286.7.821","article-title":"Comparison of evidence of treatment effects in randomized and nonrandomized studies","volume":"286","author":"Ioannidis","year":"2001","journal-title":"JAMA"},{"key":"10.1111\/ane.12086-BIB0005|ane12086-cit-0005","first-page":"CD003277","article-title":"Treatment of Lennox-Gastaut syndrome","author":"Hancock","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/ane.12086-BIB0006|ane12086-cit-0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.seizure.2009.10.003","article-title":"Cost-utility analysis of rufinamide versus topiramate and lamotrigine for the treatment of children with Lennox-Gastaut syndrome in the United Kingdom","volume":"19","author":"Verdian","year":"2010","journal-title":"Seizure"},{"key":"10.1111\/ane.12086-BIB0007|ane12086-cit-0007","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2165\/11313640-000000000-00000","article-title":"The cost effectiveness of rufinamide in the treatment of Lennox-Gastaut syndrome in the UK","volume":"28","author":"Benedict","year":"2010","journal-title":"Pharmacoeconomics"},{"key":"10.1111\/ane.12086-BIB0008|ane12086-cit-0008","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1212\/WNL.0b013e318232de76","article-title":"Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome","volume":"77","author":"Ng","year":"2011","journal-title":"Neurology"},{"key":"10.1111\/ane.12086-BIB0009|ane12086-cit-0009","volume-title":"Statistical methods for meta-analysis","author":"Hedges","year":"1985"},{"key":"10.1111\/ane.12086-BIB0010|ane12086-cit-0010","volume-title":"Statistical power analysis for the behavioral sciences","author":"Cohen","year":"1988","edition":"2"},{"key":"10.1111\/ane.12086-BIB0011|ane12086-cit-0011","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJM199301073280105","article-title":"Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome)","volume":"328","author":"The Felbamate Study Group in Lennox-Gastaut Syndrome","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1111\/ane.12086-BIB0012|ane12086-cit-0012","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1056\/NEJM199712183372504","article-title":"Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group","volume":"337","author":"Motte","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1111\/ane.12086-BIB0013|ane12086-cit-0013","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1212\/WNL.52.9.1882","article-title":"A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group","volume":"52","author":"Sachdeo","year":"1999","journal-title":"Neurology"},{"key":"10.1111\/ane.12086-BIB0014|ane12086-cit-0014","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1212\/01.wnl.0000303813.95800.0d","article-title":"Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome","volume":"70","author":"Glauser","year":"2008","journal-title":"Neurology"},{"key":"10.1111\/ane.12086-BIB0015|ane12086-cit-0015","unstructured":"Lamotrigine summary of product characteristics http:\/\/us.gsk.com\/products\/assets\/us_lamictal.pdf"},{"key":"10.1111\/ane.12086-BIB0016|ane12086-cit-0016","unstructured":"Topiramate summary of product characteristics http:\/\/www.janssenmedicalinformation.com\/assets\/pdf\/products\/files\/Topamax\/pi\/LIB-TOP-068362-08.pdf"},{"key":"10.1111\/ane.12086-BIB0017|ane12086-cit-0017","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1528-1157.1989.tb05321.x","article-title":"Double-blind, placebo-controlled evaluation of cinromide in patients with the Lennox-Gastaut Syndrome","volume":"30","author":"The Group for the Evaluation of Cinromide in the Lennox-Gastaut Syndrome","year":"1989","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12086-BIB0018|ane12086-cit-0018","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1528-1157.1989.tb05323.x","article-title":"Clinical study of oral administration of DN-1417, a TRH analog, in patients with intractable epilepsy","volume":"30","author":"Inanaga","year":"1989","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12086-BIB0019|ane12086-cit-0019","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1528-1157.1998.tb01411.x","article-title":"The efficacy of lamotrigine in children and adolescents with refractory generalized epilepsy: a randomized, double-blind, crossover study","volume":"39","author":"Eriksson","year":"1998","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12086-BIB0020|ane12086-cit-0020","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ejpn.2008.12.005","article-title":"Treatment of Lennox-Gastaut Syndrome (LGS)","volume":"13","author":"Ferrie","year":"2009","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1111\/ane.12086-BIB0021|ane12086-cit-0021","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2147\/TCRM.S4282","article-title":"Onset of action and seizure control in Lennox-Gaustaut syndrome: focus on rufinamide","volume":"5","author":"Saneto","year":"2009","journal-title":"Ther Clin Risk Manag"},{"key":"10.1111\/ane.12086-BIB0022|ane12086-cit-0022","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2147\/NDT.S5300","article-title":"Update on the management of Lennox-Gastaut syndrome with a focus on rufinamide","volume":"5","author":"Stafstrom","year":"2009","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1111\/ane.12086-BIB0023|ane12086-cit-0023","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1177\/0883073809350508","article-title":"Safety and tolerability of rufinamide in children with epilepsy: a pooled analysis of 7 clinical studies","volume":"24","author":"Wheless","year":"2009","journal-title":"J Child Neurol"},{"key":"10.1111\/ane.12086-BIB0024|ane12086-cit-0024","doi-asserted-by":"crossref","first-page":"24S","DOI":"10.1177\/0883073809338153","article-title":"Managing severe epilepsy syndromes of early childhood","volume":"24","author":"Wheless","year":"2009","journal-title":"J Child Neurol"},{"key":"10.1111\/ane.12086-BIB0025|ane12086-cit-0025","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1586\/ern.10.51","article-title":"Rufinamide: a new antiepileptic drug treatment for Lennox-Gastaut syndrome","volume":"10","author":"Ferrie","year":"2010","journal-title":"Expert Rev Neurother"},{"key":"10.1111\/ane.12086-BIB0026|ane12086-cit-0026","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1345\/aph.1M679","article-title":"Rufinamide: a new antiepileptic medication for the treatment of seizures associated with Lennox-Gastaut syndrome","volume":"44","author":"Wisniewski","year":"2010","journal-title":"Ann Pharmacother"},{"key":"10.1111\/ane.12086-BIB0027|ane12086-cit-0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta9260","article-title":"Indirect comparisons of competing interventions","volume":"9","author":"Glenny","year":"2005","journal-title":"Health Technol Assess"},{"key":"10.1111\/ane.12086-BIB0028|ane12086-cit-0028","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/bmj.331.7521.897","article-title":"Simultaneous comparison of multiple treatments: combining direct and indirect evidence","volume":"331","author":"Caldwell","year":"2005","journal-title":"BMJ"},{"key":"10.1111\/ane.12086-BIB0029|ane12086-cit-0029","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1002\/sim.1875","article-title":"Combination of direct and indirect evidence in mixed treatment comparisons","volume":"23","author":"Lu","year":"2004","journal-title":"Stat Med"},{"key":"10.1111\/ane.12086-BIB0030|ane12086-cit-0030","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1600-0404.2008.01004.x","article-title":"Benzodiazepines in epilepsy: pharmacology and pharmacokinetics","volume":"118","author":"Riss","year":"2008","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/ane.12086-BIB0031|ane12086-cit-0031","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.yebeh.2012.09.039","article-title":"Long-term safety and efficacy of clobazam for Lennox-Gastaut syndrome: interim results of an open-label extension study","volume":"25","author":"Ng","year":"2012","journal-title":"Epilepsy Behav"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fane.12086","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ane.12086\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:46:40Z","timestamp":1671540400000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ane.12086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,15]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,8]]}},"URL":"https:\/\/doi.org\/10.1111\/ane.12086","relation":{},"ISSN":["0001-6314"],"issn-type":[{"value":"0001-6314","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2,15]]}}}